Literature DB >> 18182537

Medicare Part D prescription drug benefits and administrative burden in the care of dually eligible psychiatric patients.

Joshua E Wilk1, Joyce C West, Donald S Rae, Maritza Rubio-Stipec, Jennifer J Chen, Darrel A Regier.   

Abstract

OBJECTIVE: With implementation of Medicare Part D, concerns were raised that patients with severe mental illness who were dually eligible for both Medicaid and Medicare benefits would be at clinical risk. In addition to concerns about medication access and continuity, there were concerns about administrative burden for physicians and their staffs. This study aimed to quantify the amount of administrative burden for psychiatrists and their staff related to Medicare Part D prescription drug plan administration in a national sample of dually eligible psychiatric patients and to identify factors associated with increased burden.
METHODS: A total of 5,833 psychiatrists were randomly selected from the American Medical Association's Physicians Masterfile. Responses were obtained from 64% (N=3,247) with a mailed survey using practice-based survey research methods during the first four months of Medicare Part D implementation (January to April 2006); 1,183 psychiatrists met eligibility requirements.
RESULTS: Psychiatrists and their staff spent 45 minutes in administrative tasks for every one hour of direct patient care for dually eligible patients. Drug plan features, including prior authorization and preferred drug formularies, and medication access problems were associated with increased administrative time.
CONCLUSIONS: Results of this study indicate several drug plan features and medication access problems related to Part D implementation were associated with significant increases in administrative burden for psychiatrists and their staff, which may result in less time for direct patient care. Given the vulnerability of this high-risk population, this increased administrative burden may pose a significant risk to the overall quality of care for psychiatric patients.

Entities:  

Mesh:

Year:  2008        PMID: 18182537     DOI: 10.1176/ps.2008.59.1.34

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  6 in total

Review 1.  Medicare part D and long-term care: a systematic review of quantitative and qualitative evidence.

Authors:  Camilla B Pimentel; Kate L Lapane; Becky A Briesacher
Journal:  Drugs Aging       Date:  2013-09       Impact factor: 3.923

2.  Roles of community helpers in using the Medicare Part D benefit.

Authors:  Melissa Anne Hensley
Journal:  J Health Care Poor Underserved       Date:  2011-02

3.  Uncompensated medical provider costs associated with prior authorization for prescription medications in an HIV clinic.

Authors:  James L Raper; James H Willig; Hui-Yi Lin; Jeroan J Allison; M Bennet Broner; Michael J Mugavero; Michael S Saag
Journal:  Clin Infect Dis       Date:  2010-09-15       Impact factor: 9.079

4.  The effect of depression and cognitive impairment on enrollment in Medicare Part D.

Authors:  Kara Zivin; Mohammed U Kabeto; Helen C Kales; Kenneth M Langa
Journal:  J Am Geriatr Soc       Date:  2009-06-08       Impact factor: 5.562

5.  Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges.

Authors:  Stephen Crystal; Mark Olfson; Cecilia Huang; Harold Pincus; Tobias Gerhard
Journal:  Health Aff (Millwood)       Date:  2009-07-21       Impact factor: 6.301

6.  Prior authorization for antidepressants in Medicaid: effects among disabled dual enrollees.

Authors:  Alyce S Adams; Fang Zhang; Robert F LeCates; Amy Johnson Graves; Dennis Ross-Degnan; Daniel Gilden; Thomas J McLaughlin; Christine Lu; Connie M Trinacty; Stephen B Soumerai
Journal:  Arch Intern Med       Date:  2009-04-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.